Articles From: Oshkosh Corporation Reports Fourth Quarter and Fiscal 2014 Results to Osisko Reports Third Quarter Results


Oshkosh Corporation (NYSE: OSK) today reported fiscal 2014 fourth quarter net income of $77.8 million, or $0.93 per diluted share, compared to $35.7 million, or $0.40 per diluted share, in the fourth quarter of fiscal 2013.
Sign-up for Oshkosh Corporation Reports Fourth Quarter and Fiscal 2014 Results investment picks
Oshkosh Corporation (NYSE: OSK), a leading manufacturer of specialty vehicles and vehicle bodies, will issue its fourth quarter fiscal 2014 financial results on Friday, October 31, 2014.
Sign-up for Oshkosh Corporation to Announce Fourth Quarter Earnings October 31, 2014 investment picks
Oshkosh Corporation (NYSE:OSK) announced today that it will present at Baird’s 2014 Industrial Conference being held at the Four Seasons Hotel in Chicago, Illinois on Tuesday, November 11, 2014.
Sign-up for Oshkosh Corporation to Present at Baird’s 2014 Industrial Conference investment picks
Oshkosh Corporation (NYSE: OSK) today announced the release of its inaugural Corporate Sustainability Report.
Sign-up for Oshkosh Corporation Unveils Its First Sustainability Report and Website investment picks
Oshkosh Defense , LLC, an Oshkosh Corporation (NYSE: OSK) company, announced today that its Light Combat Tactical All-Terrain Vehicle ( L-ATV ) successfully completed Limited User Testing (LUT) with the U.S. Army and Marine Corps for the Joint Light Tactical Vehicle ( JLTV ) Engineering and Manufacturing Development (EMD) contract.
Sign-up for Oshkosh Defense L-ATV Achieves Key Milestone in JLTV Program Testing investment picks
Just weeks after successfully completing the U.S. Government’s Production Readiness Review (PRR) for the Joint Light Tactical Vehicle (JLTV) program, Oshkosh Defense , an Oshkosh Corporation (NYSE: OSK) company, will showcase its JLTV solution – the Light Combat Tactical All-Terrain Vehicle ( L-ATV ) – at the Association of the United States Army (AUSA) 2014 Annual Meeting and Exposition in Washington, D.C. “Oshkosh Defense is ready for JLTV production,” said U.S. Army Major General (Retired) John Urias, executive vice president of Oshkosh Corporation and president of Oshkosh Defense.
Sign-up for Oshkosh Defense Showcases High-Performance, Production-Ready JLTV at AUSA 2014 investment picks
Oshkosh Defense , an Oshkosh Corporation (NYSE: OSK) company, will be displaying its Joint Light Tactical Vehicle (JLTV) solution at Modern Day Marine in Quantico, Va.
Sign-up for Oshkosh Defense Showcases Its Best Value JLTV Solution at Modern Day Marine investment picks
Oshkosh Defense , an Oshkosh Corporation (NYSE:OSK) company, today announced that it has successfully completed the U.S. Government’s Production Readiness Review (PRR) for the Joint Light Tactical Vehicle ( JLTV ) Engineering and Manufacturing Development (EMD) contract.
Sign-up for Oshkosh Defense Successfully Completes JLTV Production Readiness Review investment picks
Oshkosh Airport Products, LLC, an Oshkosh Corporation (NYSE: OSK) company, has placed six new generation Oshkosh® Striker® aircraft rescue and firefighting vehicles into service at Manchester Airport in the United Kingdom.
Sign-up for Oshkosh Striker Chosen by U.K.’s Manchester International; Fleet of Six New Generation ARFF Vehicles on Duty investment picks
OSI Systems, Inc. (Nasdaq: OSIS ) today announced that it will hold its quarterly conference call on Thursday, October 23, 2014 at 9:00am PT (12:00pm ET) to discuss its results for the quarter ended September 30, 2014.
Sign-up for OSI Systems Announces First Quarter Conference Call investment picks
OSI Systems, Inc. (NASDAQ: OSIS) today announced that its Security division, Rapiscan Systems, and the Department of Homeland Security (DHS) have entered into an Addendum to the Administrative Agreement signed in June 2013.
Sign-up for OSI Systems Reaches Agreement with DHS investment picks
OSI Systems, Inc. (NASDAQ: OSIS), today announced that OSI Electronics, a business within its Optoelectronic and Manufacturing division, has received orders for approximately $7 million for electronic sub-assemblies from an OEM focused on providing advanced computing and storage solutions to the aerospace and defense industries.
Sign-up for OSI Systems Receives $7 Million Award for Electronic Sub-Assemblies investment picks
OSI Systems, Inc. (NASDAQ: OSIS) today announced financial results for the quarter ended September 30, 2014.
Sign-up for OSI Systems Reports First Quarter Fiscal 2015 Financial Results investment picks
OSI Systems, Inc. (NASDAQ:OSIS), today announced it is scheduled to present at the 5 th Annual Credit Suisse Small & Mid Cap Conference on September 17 , 2014 at 11:30AM ET in New York City, NY.
Sign-up for OSI Systems to Present at the 5th Annual Credit Suisse Small and Mid Cap Conference investment picks
OSI Systems, Inc .
Sign-up for OSI Systems to Present at the Imperial Capital Security Investor Conference investment picks
Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading cellular and regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, announced today that it has entered into an exclusive commercial and development partnership for its cartilage product, Cartiform, with Arthrex, Inc. Arthrex is a global medical device company and the leader in new product development and medical education in orthopaedics and sports medicine, operating in over 90 countries throughout the world.
Sign-up for Osiris and Arthrex announce an exclusive partnership for the commercialization and development of Cartiform® investment picks
Osiris Therapeutics, Inc. (NASDAQ:OSIR), the leading cellular regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, is pleased to announce the expansion of the management team with the appointment of Adrian Mollo as General Counsel and Dr.
Sign-up for Osiris Therapeutics Announces Expansion of the Leadership Team investment picks
Osiris Therapeutics, Inc. (NASDAQ: OSIR) today announced that it will report its financial results for third quarter ended September 30, 2014, on Friday, November 7, 2014.
Sign-up for Osiris Therapeutics Announces Third Quarter 2014 Financial Results Conference Call investment picks
Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading cellular and regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedic and sports medicine, announced today its financial results for the third quarter of 2014.
Sign-up for Osiris Therapeutics Announces Third Quarter 2014 Financial Results: Revenue up 29% and Company Turned Profitable investment picks
Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading cellular regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopedics and sports medicine markets, announced today that Lode Debrabandere, Ph.D., President and Chief Executive Officer, is scheduled to present at the Stem Cell Meeting on the Mesa, on Tuesday, October 7, 2014 at 5:15 p.m. PST in La Jolla, CA.
Sign-up for Osiris Therapeutics to Present at the 2014 Stem Cell Meeting on the Mesa investment picks
Osiris Therapeutics, Inc. (NASDAQ:OSIR), the leading cellular regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, announced today that Lode Debrabandere, Ph.D., President and Chief Executive Officer, is scheduled to present at the 26 th Annual Piper Jaffray Healthcare Conference on Tuesday, December 2, 2014 at 3:00 p.m. ET in New York City.
Sign-up for Osiris Therapeutics to Present at the 26th Annual Piper Jaffray Healthcare Conference investment picks
Osiris Therapeutics, Inc. (NASDAQ:OSIR), the leading cellular and regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, announced today that Lode Debrabandere, Ph.D., President and Chief Executive Officer, is scheduled to present at the Canaccord Genuity Medical Technology and Diagnostics Forum on Thursday, November 20, 2014 at 9:00 a.m. ET in New York City.
Sign-up for Osiris Therapeutics to Present at the Canaccord Genuity Medical Technology and Diagnostics Forum investment picks
Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading cellular regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, will present findings of three wound care related studies this Friday, October 17, at the Symposium on Advanced Wound Care in Las Vegas, Nevada.
Sign-up for Osiris to present three studies on benefits of cryopreserved placental membranes for chronic wounds investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0979390001&sourceType=1 http://media3.marketwire.com/logos/20140725-OSK_logo_200.jpg http://www.ccnmatthews.com/logos2/virginia.jpg MONTREAL AND QUEBEC CITY, QUEBEC --
Sign-up for Osisko and Virginia Announce Business Combination to Create a Leading Intermediate Gold Royalty Company investment picks
2014/11/27
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0981228001&sourceType=1 http://media3.marketwire.com/logos/20140725-OSK_logo_200.jpg MONTREAL, QUEBEC --
Sign-up for Osisko Announces Closing of $100 Million Credit Facility investment picks
2014/11/28
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0981491001&sourceType=1 http://media3.marketwire.com/logos/20140725-OSK_logo_200.jpg MONTREAL, QUEBEC --
Sign-up for Osisko Announces TSX Approval for Normal Course Issuer Bid investment picks
2014/11/25
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0980845001&sourceType=1 http://media3.marketwire.com/logos/20140725-OSK_logo_200.jpg MONTREAL, QUEBEC --
Sign-up for Osisko Appoints Francoise Bertrand to Board of Directors investment picks
2014/11/26
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0981144001&sourceType=1 http://media3.marketwire.com/logos/20140725-OSK_logo_200.jpg MONTREAL, QUEBEC --
Sign-up for Osisko Closes Private Placements with CDPQ and the Fonds for Proceeds of $42 Million investment picks
2014/11/5
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0977334001&sourceType=1 http://media3.marketwire.com/logos/20140725-OSK_logo_200.jpg MONTREAL, QUEBEC --
Sign-up for Osisko Reports Third Quarter Results investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Oshkosh Corporation Reports Fourth Quarter and Fiscal 2014 Results to Osisko Reports Third Quarter Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent